ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.60
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36845
-0.05%
Bitcoin
69,405.19
0.44%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) News

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateTimeSourceHeadlineSymbolCompany
05/21/20246:05AMGlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
05/10/20243:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
05/09/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
05/09/20243:05PMGlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
05/08/20243:15PMGlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
04/30/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
04/16/20246:05AMGlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
04/02/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
03/18/20246:05AMGlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical OfficerNASDAQ:CLSDClearside Biomedical Inc
03/12/20243:05PMGlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
02/29/20246:05AMGlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024NASDAQ:CLSDClearside Biomedical Inc
02/08/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
02/08/20243:52PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLSDClearside Biomedical Inc
02/07/20247:00AMGlobeNewswire Inc.Clearside Biomedical Announces Pricing of $15 Million Registered Direct OfferingNASDAQ:CLSDClearside Biomedical Inc
02/01/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
01/19/20245:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
01/19/20242:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLSDClearside Biomedical Inc
12/28/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
12/14/20236:05AMGlobeNewswire Inc.Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
11/13/20233:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
11/13/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
11/13/20233:05PMGlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
11/08/20236:05AMGlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
11/07/20233:20PMGlobeNewswire Inc.Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
11/03/202311:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
11/03/202311:00AMGlobeNewswire Inc.BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®NASDAQ:CLSDClearside Biomedical Inc
11/02/20236:05AMGlobeNewswire Inc.Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
11/01/20236:05AMGlobeNewswire Inc.Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
10/31/20236:05AMGlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023NASDAQ:CLSDClearside Biomedical Inc
10/16/20236:05AMGlobeNewswire Inc.Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Your Recent History

EU
ENAE
Bouygues SA 1.1250% unti...
EU
CAHBQ
Credit Agricole Home Loa...
NYSE
KRK
Str PD 7.2 Ibm
NASDAQ
AAZEAXX
Bofa Finance Llc Autocal...
COIN
DFGBP
dForce
COIN
STLBTC
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved